Skip to main content

Site notifications

(Approval lapsed 17/09/2020) Gentamicin 80mg/2mL injection

Section 19A approved medicine
(Approval lapsed 17/09/2020) Gentamicin 80mg/2mL injection
Section 19A approval holder
Link Medical Products Pty Ltd ABN 73 010 971 516
Phone
1800 181 060
Approved until
Status
Lapsed
Medicines in short supply/unavailable
DBL GENTAMICIN 80mg/2mL Injection BP - ARTG 47268
Indication(s)

For the treatment of infections due to one or more susceptible strains of bacteria, including Pseudomonas aeruginosa, Proteus species (indole positive and indole negative), Escherichia coli, Klebsiella, Enterobacter and Serratia species and Staphylococcus (including strains resistant to other antibiotics). Gentamicin may also be used for the treatment of the following conditions when caused by susceptible organisms: bacteraemia, respiratory tract infections, urinary tract infections, skin and skin structure infections, bone infections, peritonitis, and burns complicated by sepsis. Aminoglycosides, including gentamicin are generally not indicated in uncomplicated initial episodes of urinary tract infection unless the causative organisms are not susceptible to less toxic antibiotics.

Help us improve the Therapeutic Goods Administration site